Twice-Daily Use of Biphasic Insulin Aspart 30 (BIAsp 30): Comparative Studies A total of seven publications (three papers and four abstracts) from five studies were identified that compared twice ...

reported interim results of a 3 year, open-label, randomized, controlled, multicenter trial comparing the efficacy and safety of adding biphasic, prandial or basal insulin to oral therapy for ...

The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in ...